Notch1-Delta-like 4 (Dll4) signaling controls vascular development by regulating endothelial cell (EC) targets that modulate vessel wall remodeling and arterial-venous specification. The molecular effectors that modulate Notch signaling during vascular development remain largely undefined. Here we demonstrate that the transcriptional repressor, Snail1, acts as a VEGF-induced regulator of Notch1 signaling and Dll4 expression. EC-specific Snail1 loss-of-function conditional knockout mice die in utero with defects in vessel wall remodeling in association with losses in mural cell investment and disruptions in arterial-venous specification. Snail1 loss-of-function conditional knockout embryos further display up-regulated Notch1 signaling and Dll4 expression that is partially reversed by inhibiting Ɣ-secretase activity in vivo with Dll4 identified as a direct Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use
INTRODUCTION
The evolutionarily conserved Notch signaling pathway plays critical roles in controlling multiple aspects of vascular development and EC (EC) function, ranging from proliferation, motility and lumen formation to vessel stability and cell fate determination 1, 2 . In vertebrates, the Notch signaling pathway consists of four Notch family receptors (Notch1 through to Notch4) and five Notch ligands [(Jagged1, Jagged2, Delta-like (Dll) 1, Dll3 and Dll4)] 2 . Receptor-ligand interactions between neighboring cells initiates the proteolytic cleavage of the Notch receptor extracellular domain, the Ɣ-secretase-dependent release of the Notch intracellular domain (NICD), and its subsequent translocation to the nucleus where it associates with the DNA-binding protein, RBPJK/CBF1/Su(H), as well as a coactivator of the Mastermind-like (MAML) family, thereby triggering the transcription of downstream target genes, including Hey/Hes family members 2 . EC-specific deletion or overexpression of key components of the Notch signaling pathway, e.g., Notch1, its transcriptionally active intracellular form (N1ICD) or Dll4, impinges on the normal development of the embryonic vasculature and results in early embryonic lethality [3] [4] [5] . Recent studies suggest that VEGF, ETS factors, Sox and Notch regulate Dll4 expression in complex cascades that may be further impacted by the canonical Wnt pathway 1, [6] [7] [8] [9] . However, despite the fact that even subtle changes in Dll4 expression impair vascular development 2, 4, [10] [11] [12] , the regulatory systems that fine-tune Dll4/Notch signaling during the development of the embryonic vasculature in vivo remain largely undefined.
The zinc-finger transcriptional repressor, Snail1, has been shown to play an essential role in the induction of epithelial-mesenchymal transition (EMT) and gastrulation in the developing mouse embryo 13 . Mouse embryos homozygous for a Snail1-null mutation (Snail1 −/− embryos) display defects in mesoderm formation and die shortly after embryonic day (E) 7.5 14 . Recently, Gridley and colleagues reported that the epiblast-specific deletion of Snail1 at later stages in mouse embryonic development is permissive for normal gastrulation, but results in defective left-right asymmetry determination and cardiovascular development 15, 16 . However, as all embryonic tissues were rendered Snail1 deficient in these studies, the possibility that Snail1 functions in an EC-autonomous fashion in vivo remains unexplored.
Here we report that EC-specific Snail1 loss-of-function (LOF) conditional knockout mice display an early embryonic lethal phenotype with marked defects in vascular remodeling, morphogenesis and arterial-vein specification. Unexpectedly, the observed changes in vascular development phenocopy a subset of the defects commonly associated with upregulated Dll4/Notch1 signaling [4] [5] [6] . Indeed, we now identify Snail1 as a VEGF-induced, cisacting, negative feedback regulator of Dll4 and Notch1 expression in vitro and in vivo. These studies identify a novel, EMT-independent function of Snail1 whereby the transcription factor as a required regulator of the Notch signaling cascade that controls vascular development during embryogenesis.
RESULTS

EC-specific Snail1 Deletion Leads to Embryonic Lethality
To interrogate a potential role for Snail1 during embryonic vascular development, conditional Snail1 fl/fl mice 17 were crossed with a Tie2-Cre transgenic line, thereby targeting Cre recombinase in ECs as well as hematopoietic stem cells 18 . Under these conditions, no viable pups expressing Snail1 fl/fl ;Tie2-Cre + (i.e., Snail1 LOF mutants) were born ( Fig. 1a and Table 1 ). In timed matings, Snail1 LOF embryos are morphologically indistinguishable from control embryos (i.e., littermates expressing Snail1 fl/wt ;Tie2-Cre + or Snail1 fl/fl ;Tie2-Cre − ) up to E9.5 (Fig. 1a) . However, by E10.5 and E11.5, Snail1 LOF mutant embryo size (crown-rump length) is decreased by 32% and 47%, respectively, as compared to their control littermates (Fig. 1b) . Furthermore, ~50 and 100% of Snail1 LOF embryos die at E11.5 or 12.5, respectively ( Table 1 ), demonstrating that the Tie2-Cre-driven deletion of Snail1 dramatically impacts early embryonic development.
To further specify the cell lineage that contributes to Snail1 LOF-induced embryonic lethality, conditional Snail1 fl/fl mice were crossed with a Vav1-Cre line that drives Cre recombinase expression specifically in hematopoietic cells during definitive hematopoiesis 19 . In marked contrast to the Tie2-Cre + mice, analysis of embryos at E14.5, E17.5 or postnatal day 1 (P1) demonstrated no differences in viability or gross morphology between Snail1 fl/fl ;Vav1-Cre + mutants and control littermates expressing Snail1 fl/wt ;Vav1-Cre + or Snail1 fl/fl ;Vav1-Cre − (Fig. 1c and Table 2 ), indicating that Snail1 deletion confined to hematopoietic cells alone does not phenocopy Snail1 LOF mutants. As yolk sac-derived blood islands serve as the sole source of primitive hematopoietic cell production up to E9.5 (a stage before Vav1-Cre is expressed) 20 , we further used hematopoietic colony-forming assays to assess the potential impact of Tie2-Cre-mediated Snail1 deletion on early stages of hematopoiesis. However, in vitro differentiation of yolk sac hematopoietic progenitor cells derived from E9.5 Snail1 LOF mutants and control littermates demonstrates comparable erythroid colony formation (CFU-E and BFU-E) (Fig. 1d,e) . Taken together, these data support a model wherein the loss of Snail1 expression in the endothelial compartment is incompatible with early embryonic development.
Snail1 LOF Mutant Embryos Display Vascular Deficits
At E10.5, Snail1 LOF embryos are smaller in size with associated defects in the patterning of several regions of the vascular tree despite similar somite numbers (35 ± 3 somites in WT versus 33 ± 2 somites in LOF; n=4) ( Fig. 2a-f) . Cranial blood vessels fail to undergo the remodeling events that normally lead to the generation of larger caliber vessels (compare Figures 2a and 2d boxed areas) . Vascularization of the tail is impaired in Snail1 LOF embryos with the formation of truncated and disorganized networks (Fig. 2b,e,g ). Intersomitic vessels (ISV), formed through angiogenic sprouting 21 , are present in the Snail1 LOF mutant embryos, but are unable to organize or fully infiltrate the somites (compare Figures 2c and 2f) , displaying significant decreases in ISV length and branch points (Fig.  2h,i) . While Snail1 can exert anti-apoptotic effects in expressing cell populations 22 , no differences in the number of TUNEL-positive ECs within the dorsal aorta (DA) or surrounding vessels are observed between WT and Snail1 LOF embryos ( Supplementary  Fig. 1a-c) .
Independent of vascular patterning defects, immunostaining for alpha-smooth muscle actin (α-SMA), a marker for vascular smooth muscle cells, demonstrates that while the DA of WT E10.5 embryos are surrounded by α-SMA-positive cells, arteries in Snail1 LOF embryos fail to develop a well-developed, α-SMA-positive mural coats (Fig. 2j-q) . Interestingly, using Snail1 LacZ/wt mice 23 , β-galactosidase reporter activity is not only detected in PECAM-1-positive ECs within the DA, vitelline artery (VA) and cardinal vein (CV), but also in PECAM-1-negative, perivascular cells surrounding arterial beds (Fig. 2r and Supplementary Fig. 2a-j) . To determine whether perivascular Snail1 is also required during embryonic development, Snail1 fl/fl mice were next crossed with a Dermo1-Cre transgenic line 24 , thereby targeting Cre recombinase throughout the mesoderm, including the mural cell compartment as assessed in Dermo1-Cre + ;Rosa26 crosses 25, 26 (Fig. 2s) . However, analyses of embryos at E14.5 or P1 demonstrated no differences in viability or gross morphology between Snail1 fl/fl ;Dermo1-Cre + mutants and control littermates expressing Snail1 fl/fl ;Dermo1-Cre − ( Fig. 2t and Table 3 ), indicating that Snail1 expression in mural cell populations does not play a major role during embryonic vascular development.
Outside the embryo proper, yolk sacs in Snail1 LOF mutants at E10.5 display multiple vascular defects, including gross reductions in the number of perfused blood vessels in combination with marked tissue pallor (compare Figure 3a,d) . Strikingly, PECAM-1 wholemount staining reveals the severely defective remodeling of the primary vascular plexus into both hierarchical and branched vessels in the Snail1 LOF yolk sacs (compare Figure 3b,e) . Further, α-SMA staining demonstrates that while arteries of WT yolk sacs are surrounded by α-SMA-positive cells, vessels in Snail1 LOF yolk sacs fail to develop α-SMA-positive mural coats (compare insets in Fig. 3b ,e). Quantification of vascularization (i.e., small and large vessels arising from the primordial vascular plexus) highlights the almost complete loss of vessel remodeling in Snail1 LOF mutants at E10.5 (Fig. 3g) . The vascular phenotype of mutants further progressed until E11.5, at which time ~50% of embryos are necrotic with no intact vascular structures remaining (compare Figure 3c,f) . Vascular defects are also observed in the labyrinthine layer of the placenta, a tissue that is essential for gas and nutrient exchange during gestation 27 ( Supplementary Fig. 3a-f) . Under normal conditions, the allantois attaches to the chorionic plate (the initial step in the formation of a functional placenta), which is followed by vascular invasion of the labyrinthine layer 27 . In Snail1 LOF mutants, however, although the chorionic plate and trophoblast giant cells appear normal in structure and number, the labyrinthine layer is reduced in thickness and vascularization relative to WT littermates ( Supplementary Fig. 3a-f) . Further, in Snail1 LOF mutants, the number of fetal blood vessels that invade and interdigitate into the labyrinthine layer is reduced markedly (Supplementary Fig. 3a-f ).
Snail1 Directs Vessel Patterning Independent of Vascular Flow
Given the global defects in vascular organization observed in Snail1 LOF embryos, we next considered the possibility that Snail1 may alter cardiac function with consequent (but indirect) effects on blood flow-induced vasculogenesis/angiogenesis 28 . As such, vascular remodeling was assessed ex vivo by isolating the allantois from E8.25 WT and Snail1 LOF littermates and following their reorganization into vascular networks in explant cultures 29 . In the ex vivo system, cultured allantoises engage a vascularization program similar, if not identical, to that observed in vivo with no requirements for vascular flow 29 . At pre-culture, allantois explants derived from Snail1 LOF mutants exhibit an immature vascular pattern similar to that observed in WT littermates (Fig. 3h,k) . By contrast, at 24 h post-culture, whereas WT explants readily undergo vascular morphogenesis while expressing Snail1 (as assessed in explants isolated from Snail1 LacZ/wt reporter mice) (Fig. 3i,j and Supplementary  Fig. 3g,h ), Snail1 LOF explants display an almost complete defect in their ability to organize into vascular networks (Fig. 3i-n) . Under these conditions, no significant differences in TUNEL-positive ECs were observed between WT and Snail1 LOF mutant explant cultures ( Supplementary Fig. 3i ), highlighting the importance of Snail1 in supporting neovessel formation under flow-independent conditions. To further assess a vascular EC-specific role of Snail1 in controlling the angiogenic program in vivo, the ability of WT and Snail1 KO ECs to support neovessel formation in a transplant assay system was assessed 30 . To this end, ECs were isolated from β-actin-eGFP;Snail1 fl/fl mice and transduced with either a control Adeno-βgal or an Adeno-Cre construct in vitro and stimulated with VEGF (Fig. 4a ). As shown in Fig. 4b , VEGF-stimulated ECs markedly increase Snail1 protein levels in Adeno-βgal infected cells, but not in Adeno-Cre expressing cells. Furthermore, when GFP-expressing control ECs are seeded into poly-L-lactic acid scaffolds and transplanted into recipient immunoincompetent hosts, neovessels are formed readily (Fig. 4c,d ). As such, the ability of control and Snail1-deleted ECs to mount an angiogenic response in recipient mice was assessed in the absence or presence off exogenous VEGF. In the absence of VEGF, Adeno-βgal transduced-ECs form small networks of GFP + /PECAM-1 + vascular structures (Fig. 4e,f) . By contrast, Snail1-deleted ECs are unable to organize into vascular networks (Fig. 4g,h ). Following VEGF supplementation, Adeno-βgal-transduced ECs dramatically enhance their angiogenic potential, while Snail1-deleted ECs are unable to mount morphogenic responses despite the fact that these 2 wk-old implants contain larger numbers of single ECs with no increase in apoptosis ( Fig. 4i and Supplementary Fig. 4 ). Taken together, these data support an ECautonomous role for Snail1 in supporting the angiogenic program.
EC-Specific Deletion of Snail1 Up-Regulates Notch Signaling
To assess the global impact of Snail1 expression on endothelial function in an unbiased fashion, primary ECs isolated from E10.5 Snail1 fl/fl embryos were transduced with either a control Adeno-β-gal or an Adeno-Cre construct in vitro, RNA isolated and subjected to transcriptional profiling. Remarkably, using a minimum of 2.0 fold change as a cutoff, Snail1 deletion alters the expression of ~500 unique transcripts with marked effects noted in gene ontologies associated with angiogenesis-associated functions (Fig. 5a,b) . Unexpectedly, however, Snail1-KO ECs also display increased expression of multiple Notch targets, including Dll4, Notch1, Jag1, Hey1, guanylate cyclase 1 beta 3 (GUCY1β3), meningiomal 1 (MN1), insulin growth factor (IGF2) and fibroblast growth factor 13 (FGF13) 2, 31 . Furthermore, arterial markers, including ephrin-B2 and Depp [also known as 8430408G22Rik 32 ], are also upregulated in Snail1 KO ECs, suggesting that the deletion of Snail1 may interface with arterial specification/differentiation (Fig. 5c ). Validating the microarray data, RT-qPCR analyses confirm upregulated Notch-associated transcript levels in Snail1 KO ECs (Fig. 5d) . Furthermore, when EC lysates are subjected to immunoblotting with specific antibodies directed against Dll4 or the intracellular domain of Notch1 (N1ICD), Snail1-KO ECs markedly increase protein levels of Dll4 and N1ICD relative to WT ECs (Fig. 5e ). As these data were obtained from in vitro-cultured ECs wherein Snail1 was deleted after isolation, we sought to confirm the ability of Snail1 deletion to up-regulate Dll4/Notch signaling in vivo. Hence, the status of Notch signaling-associated transcripts was assessed in ECs freshly isolated -and without in vitro culture -from E10.5 Snail1 LOF mutant and WT embryos. Consistent with the in vitro data, purified ECs from Snail1 LOF mutants display significantly higher levels of Dll4, Notch1, Hey1 and ephrin-B2, confirming upregulated Notch signaling in the in vivo setting (Fig. 5f ). In an effort to extend these observations to increases in protein expression levels in situ, tissue sections from E10.5 WT and Snail1 LOF mutants were immunostained for Dll4 and ephrin B2. As predicted, both Dll4 and ephrin B2 levels are markedly increased in the dorsal aortae (DA) of Snail1 LOF mutant embryos (compare Fig. 5g ,h,j,k and Fig. 5m ,n,p,q). Furthermore, Snail1 LOF ECs mis-express Dll4 and ephrin B2 in cardinal vein (CV) fields (Fig. 5h ,i,k,l,n,o,q,r).
Given that the phenotype and gene expression profile of Snail1 LOF mutant mice are consistent with exaggerated Dll4-Notch1 signaling 4-6 , we next tested the ability of the Notch signaling inhibitor, DAPT, to potentially rescue a portion of the vascular defects observed in the mutant mice 6, 33 . To this end, timed pregnant mice were treated with a non-toxic, low dose of DAPT in an effort to decrease, but not totally inhibit, Notch signaling 6, 33 . Confirming the efficacy of this treatment protocol, cross-sections and whole cell lysates recovered from DAPT-treated WT embryos display a marked reduction in N1ICD expression as assessed by N1ICD immunofluorescent staining and Western blot analysis (Supplementary Fig. 5a-g ). However, whereas partial inhibition of Notch signaling does not affect vascular patterning in WT embryos, DAPT-treated Snail1 LOF embryos display improved levels of vascular remodeling/branching in both the cephalic region ( Fig. 6a-d and Supplementary Fig. 6a ,b) and yolk sac ( Fig. 6e and Supplementary Fig. 6c-h ). Further, these changes occur in tandem with decreased Notch signaling in vivo as assessed by reduced Hey1 and ephrin B2 expression (Fig. 6f) . While DAPT-treated Snail1 LOF embryos displayed a trend towards larger size, perhaps consistent with improved vascular remodeling, the differences did not reach statistical significance (Fig. 6g) . Importantly, increased vascular remodeling in Snail1-deleted cells is not confined to the in vivo setting can be confirmed ex vivo as well in DAPT-treated explants of Snail1 LOF allantoises ( Fig.  6h-l) . Finally, to determine the impact of decreasing Notch signaling in ECs directly, WT or Snail1-deleted ECs were cultured atop Matrigel hydrogels in the absence or presence of DAPT in vitro 4 . Following Snail1 excision in Adeno-Cre-transduced Snail1 f/f ECs, sprouting behavior is completely inhibited relative to Adenoβ-gal-transduced controls ( Supplementary Fig. 6i -l,q,r). Following DAPT treatment, however, Snail1-deleted ECs decreased N1ICD expression to control levels and likewise recover a significant portion of their morphogenic activity ( Supplementary Fig. 6m -r).
Snail1 Directs Transcriptional Repression of Dll4
Early embryonic lethality, defective cranial and intersomitic vessel formation, dysregulated expression of arterial markers and failures in the yolk sac remodeling of yolk SAC are all hallmarks in gain-of-function activation of the Notch1 signaling pathway, particularly the overexpression of Dll4 4, 5, 34, 35 . Given that Dll4 protein expression is enhanced in both the arterial and venous beds of Snail1 LOF mice (Fig. 5) , we next explored the possibility that Snail1 might regulate Dll4 expression directly. Snail1 exerts many of its transcriptional effects by binding to E-box elements (consensus sequence, CANNTG) within the promoter proximal region of target genes 13 . In this regard, initial searches identified multiple conserved E-box elements that are located within the proximal region of the murine Dll4 promoter (see below). Hence, 293T cells were transiently transfected with a reporter construct containing the luciferase gene under the control of full-length murine Dll4 promoter (i.e., bp −3631~+76) 6 . Under these conditions, Dll4 promoter activity is efficiently repressed when co-transfected with a Snail1 expression vector relative to the control vector ( Supplementary Fig. 7a,b) . Similarly, overexpression of Snail1 in purified ECs significantly represses Dll4 promoter activity (Fig. 7a) . To identify the minimal promoter element containing the essential regulatory regions, systematically deleted mutants of the Dll4 promoter region were constructed, and the transcriptional activities of the mutants tested in purified WT ECs (Fig. 7b) . The deletion of bp −2027~+76, bp −1156~+76 or bp −481~+76 results in a loss of 98.5%, 97.3% or 83.2% of Dll4 promoter activity, respectively, suggesting that the bp −481~+76 fragment serves as the Dll4 minimal promoter (Fig. 7b) . To further define the E-box elements (at positions +43~+48, −395~-390 and −432~-427) within this region, ECs were electroporated with reporter constructs harboring successive point mutations in the 3 E-boxes (CANNTG→AANNTA). Snail1 expression dramatically decreases luciferase activity in the WT minimal promoter sequence, but not in the mutant construct (Fig. 7c) . Conversely, while Snail1 KO ECs display a significantly increased luciferase activity when transduced with the WT minimal promoter sequence relative to WT ECs, the up-regulated activity is lost in the presence of the mutant construct (Fig. 7c,d ). Following chromatin immunoprecipitation (ChIP) of FLAG-Snail1 in transfected ECs followed by qPCR of the Dll4 promoter and upstream region, FLAG-Snail1 ChIPs are enriched in the P1 and P2 regions (containing E-box-1 and E-box-2/-3, respectively) of the Dll4 promoter, but not in the upstream P3 region, suggesting that Snail1 represses the transcriptional activity of Dll4 by specifically binding to these 3 E-box elements (Fig. 7e) . As the ability of Snail1 to repress transcriptional activity of target genes has been linked to the recruitment of histone modifying cofactors [36] [37] [38] , ChIP analyses in WT and Snail1-KO ECs were performed using antibodies directed against di-or trimethylated H3K4 (H3K4me2 or H3K4me3) and acetylated H3K9 (H3K9Ac), histone markers associated with increased transcriptional activity [36] [37] [38] . As shown in Figure 7f , the levels of H3K4me2, H3K4me3 and H3K9Ac are significantly increased at the Dll4 promoter in Snail1 KO ECs relative to WT ECs.
To address the ability of endogenously derived Snail1 to repress DII4 expression and modulate Notch signaling, control or Snail1-deleted ECs were treated with VEGF, a potent agonist of DII4 expression 7, 8, 39 . Under these conditions, VEGF-stimulated ECs increase Snail1 protein levels in tandem with increases in DII4 and N1ICD expression (Fig. 7g) . By contrast, in Snail1 KO ECs, DII4 expression at both the mRNA and protein levels is enhanced in the absence of the endogenous Snail1-dependent feedback inhibition loop, resulting in increased levels of N1ICD (Fig. 7h) . Recent studies have documented the ability of VEGF to trigger Snail1 expression in carcinoma cells 40, 41 , but the mechanisms by which VEGF regulates Snail1 in ECs have not been characterized previously. VEGF-stimulated ECs are known to activate a series of signaling cascades, including ERK, PI3K/Akt and NF-κB 10, 42, 43 , that have each been implicated previously in regulating either Snail1 mRNA or protein expression 17, [44] [45] [46] . Indeed, VEGF-dependent induction of Snail1, Dll4 and N1ICD in ECs occurs in tandem with the activating phosphorylation of ERK1/2 and Akt (Fig. 7i) . Increased activation of ERK1/2 and Akt, in turn, triggers the Ser 9 phosphorylation/ inactivation of GSK3β, the primary kinase responsible for Snail1 phosphorylation events that target the transcription factor for proteosomal destruction 17, 38, 45 (Fig. 7i) . Similar, if not identical, results were observed with bFGF, a second pro-angiogenic growth factor that likewise increases Dll4 expression in ECs 47 (Fig. 7i) . Finally, the central role played by GSK3β in Snail1 expression in ECs is confirmed by the ability of the synthetic GSK3 inhibitor, CHIR99021 48 , to directly increase EC Snail1 to near-maximal levels in the absence of either VEGF or bFGF ( Supplementary Fig. 7c ).
To next determine the potential roles of ERK and/or Akt activation in controlling the GSK3β-dependent regulation of Snail1 protein levels, ECs were pretreated with the MEK/ERK inhibitor, UO126, or the PI3K/Akt inhibitor, LY294002 17 . In the presence of either inhibitor, the VEGF-or bFGF-induced suppression of GSK3β activity is prevented, thereby blocking increases in Snail1 protein levels ( Fig. 7j and Supplementary Fig. 7d ). Furthermore, consistent with the ability of NF-κB to directly trigger Snail1 mRNA expression 44 , the specific NF-κB inhibitor, sanguinarine 46 , attenuates the VEGF-as well as bFGF-mediated upregulation of Snail1 mRNA and protein expression without affecting the VEGF-mediated suppression of GSK3β activity ( Fig. 7k and Supplementary Fig. 7d ). While previous studies have reported the ability of Notch1 signaling itself to affect Snail1 expression 49, 50 , Snail1 protein levels in VEGF-stimulated ECs are unaffected by DAPT despite an almost complete inhibition of N1ICD formation (Fig. 7l) . Together, these observations describe a regulatory axis wherein VEGF triggers increased Snail1 mRNA expression in an NF-κB-dependent manner while stabilizing Snail1 protein via the ERK/ Akt-dependent phosphorylation/ inactivation of GSK3β (Fig. 8) .
DISCUSSION
Snail1 is most frequently characterized as a zinc-finger transcriptional repressor that triggers the EMT programs critical to early embryogenesis 13 . While the epiblast-specific conditional deletion of Snail1 leads to a series of complex cardiovascular network defects 15, 16 , we now report that the conditional deletion of Snail1 in ECs leads to early embryonic lethality in association with profound alterations in vascular development. Though only a subset of ECs in the Snail1 LacZ/wt expressed β-galactosidase activity at the time points selected, these determinations do not allow for the tracking of Snail1 expression in dynamic fashion as staining only reflects the steady state concentration of the enzyme at the time of assay. Alternatively, as observed during endothelial tip cell formation, changes in gene expression limited to small subsets of the developing vasculature can exert lethal effects during embryogenesis [1] [2] [3] . Future studies using Snail1 promoter-Cre transgenic lines and ROSA indicator strains should allow for a more rigorous lineage tracking of Snail1-expressing ECs during early development.
Transcriptional profiling of WT versus Snail1-deleted ECs uncovered a surprisingly complex range of Snail1-regulated targets, but our attention was drawn to the significant increases in Notch1 signaling and DII4 expression in combination with increased levels of downstream target genes 4, 5, 31, 35, 39 . Importantly, similar changes in the Notch-DII4 signaling axis were confirmed both in vivo, in ECs isolated directly from Snail1 LOF mutant embryos and following Snail1 excision from floxed ECs in vitro. Furthermore, many of the vascular defects in vessel branching and remodeling observed in our Snail1 LOF mutants, including defects in the embryonic and extraembryonic vasculature, resemble those described in mouse embryos engineered to express constitutively active Notch1, Notch4, N1ICD or DII4 4, 5, 35, 51, 52 . Given the fact that the range of Snail1 targets within the endothelium extends far beyond the Notch1/DII4 signaling axis, it is unlikely that all of the Snail1 LOF mutant vascular phenotypes would be expected to duplicate precisely those observed in more targeted interventions designed to specifically up-regulate Notch signaling. For example, whereas Dll4 or N1ICD overexpression frequently, but not always, increases artery diameter 4, 5, 35, 47, 52 , we did not note significant effects on artery size in our model. It should be stressed, however that experimental systems designed to overexpress Notch/Notch ligands are far different from the model described herein where endogenous Snail1 was deleted, leading to more "physiologic" compensatory increase in Notch signaling. Nevertheless, many of the vascular defects observed in Snail1 LOF mutant embryos were partially reversed following DAPT treatment in vivo, in allantois explants ex vivo and in isolated ECs cultured in vitro, underlining the importance of Notch1 signalingrelated targets. Interestingly, the degree of rescue observed following treatment of Snail1 LOF mutant embryos with DAPT parallel closely those observed in an EC-specific, ß-catenin gain-of-function mutant mouse model that similarly displays enhanced DII4 expression and an embryonic lethal phenotype 6 .
Increases in Notch signaling in Snail1 LOF mutant embryos as well as isolated ECs are likely byproducts of the observed increases in both Notch1 and DII4 expression. However, as increased levels of the Notch1 receptor alone (i.e., in the absence of increased ligand expression or ligand-independent activation) are not predicted to drive, in and of themselves, robust N1ICD-dependent Notch signaling 53, 54 , our attention turned to the effects of Snail1 on DII4 expression as a potentially key effector of enhanced Notch signaling. Indeed, the DII4 promoter was found to contain a series of E-boxes that serve as binding sites critical to Snail1 transcriptional repressor activity. Hence, in tandem with the VEGF-induced increase in Dll4 expression, VEGF also triggers Snail1 transcription and the post-translational stabilization of the protein via both GSK3β -independent (i.e., NF-κB) and -dependent (i.e., ERK/Akt) pathways. In turn, Snail1 fine-tunes Dll4 protein levels, and consequently, Notch1 activity, by serving as a transcriptional repressor of Dll4 expression. While we have focused on the interplay between VEGF, Snail1 and Dll4 in regulating vascular behavior, other signaling cascades are likely engaged in vivo, including the canonical Wnt pathway 6, 9 . Of note, Wnt signaling also regulates Snail1 activity via GSK3β-dependent pathways 38, 45 , raising the possibility that each of the multiple signaling transduction cascades interfacing with Dll4 expression and Notch activity also intersect with Snail1 as a negative feedback regulator.
The ability of Snail1 to modulate Dll4 promoter expression, Dll4 mRNA or Dll4 protein levels in arterial beds, however, does not provide insights into the means by which Dll4 expression is inappropriately up-regulated in the developing venous vasculature of the Snail1 LOF mutant mice. Recent studies have established that the 5′ promoter region of Dll4 does not serve to direct arterial versus venous patterns of expression 7, 8 . Rather, the arterial endothelial cell-specific enhancer lies largely within the third Dll4 intron 7, 8 . Interestingly, however, this intron contains an RBJK-binding site, and overexpression of N1ICD alone induces the Dll4-dependent arterialization of veins 8, 34 . Indeed, Snail1 LOF mutant embryos also display increased levels of Dll4 and the N1ICD-dependent target genes, ephrin B2 and Hey1, suggesting that Snail1-dependent regulation of Dll4 expression extends beyond direct effects on the 5′ genomic region of Dll4 alone. In this regard, preliminary studies indicate that Snail1 also acts as a direct repressor of the Notch1 promoter ( Supplementary Fig. 8 ), raising the possibility that inappropriate Notch1 expression may participate in the misregulated expression of Dll4 in venous beds. The precise steps responsible for activating Notch1 in the venous beds of mutant mice require further study, but we note that Dll4 itself can exert long-distant effects following its release into exosomes and that ADAM 17 (upregulated more than 2-fold in Snail1 KO ECs) can activate Notch1 signaling in a ligandindependent fashion 54, 55 . The molecular details underlying this process notwithstanding, our data suggest that EC-derived Snail1 also plays an important role in controlling arterialvein specification during early development. As Snail1 LOF mice maintain the ability to assemble vascular plexus networks in both cranial fields and yolk sacs, major defects appear to arise in the vessel remodeling phase of development, a conclusion consistent with the observed defects in allantois explants and isolated endothelial cells. Further studies will be required to determine the degree to which Snail1 drives vessel remodeling by affecting motile responses and artery-vein specification as well as complementary processes critical to these events. Indeed, earlier studies for our laboratory have identified a role for Snail1 in regulating tissue-invasive programs that likely participate in vessel morphogenesis 17 .
The formation of a stable vasculature not only requires the induction of the necessary EC morphogenetic programs, but also the recruitment of mural cell populations (i.e., vascular smooth muscle cells or pericytes) to the abluminal wall of developing neovessels 56 . As such, we were intrigued by the fact that Snail1 LOF mutant embryos are unable to develop a mural cell coat. Similar observations have been observed following the up-regulation of Notch1 activity in vivo 5, 35 , and we considered the possibility that Snail1 induces an endothelial-mesenchymal transition (EnMT) program that allows ECs themselves to serve as mural cell precursors. However, recent EC lineage tracking studies indicate that mural cells are recruited from the surrounding mesoderm rather than from the endothelium proper 57 . Indeed, though we were able to detect Snail1 expression in perivascular cell populations, mesoderm-specific Snail1 deletion did not impact vascular development to the degree observed with EC-specific targeting. As such, Snail1 more likely controls mural cell recruitment in trans through paracrine signaling pathways (e.g., PDFG, TGFß, Ang1/Tie2 or Notch signaling) 56 . Though Snail1-dependent EnMT programs are unlikely engaged to generate mural cells during development, EC-like endocardial cells are known to express Snail1 and undergo a distinct phenotypic switch to mesenchymal-like cells in the developing cardiac cushions 2, 50, 58 . Nevertheless, the role of Snail1 in this process remains controversial with earlier reports debating its potential importance relative to that of Snail2/ Slug as the critical EnMT effector 50, 58, 59 . While prior analyses of Tie2-Cre-targeted Snail1 heterozygote mice revealed only subtle defects in cardiac cushion cellularization 60 , we have found that Snail1 LOF mutant mice are unable to activate the associated EnMT program (Supplementary Fig. 9 ). These findings serve to highlight the broader roles played by Snail1 in regulating endothelial as well as endocardial function in the developing vasculature and cardiac fields, respectively, and support a model wherein the embryonic lethal phenotype of Snail1 LOF mice arises as a consequence of multiple defects in cardiovascular development. Broader roles for the Snail1-dependent regulation of EC function may extend into the postnatal setting as well. In preliminary studies, we have attempted to delete Snail1 postnatally to determine its role in retinal development (Supplementary Fig. 10 ). Despite deleting Snail1 by ~70%, defects in retinal angiogenesis were not detected ( Supplementary  Fig. 10 ) and additional studies are underway to delete Snail1 with higher efficiency to rule out the rescue of vascular responses by ECs that escaped Cre-mediated excision. This caveat aside, we found that Snail1-deleted ECs were unable to support the wound-like angiogenic responses that occur following transplantation into adult mice. Indeed, Snail1 has been detected in the neovasculature surrounding human carcinomas, raising the possibility that Snail1-DII4 interactions direct vascular remodeling, and possibly lymphangiogenesis, in neoplastic states [61] [62] [63] [64] . As adult ECs can also inappropriately re-activate embryonic programs during pathologic fibrotic states to generate tissue fibroblasts 65 , a potential role for Snail1 in these postnatal events will be the subject of future studies.
METHODS
Mice
Mice were housed under standard condition and protocols approved by the University Committee on Use and Care of Animals (UCUCA). Mice carrying Snail1 alleles 17 and mice with Snail1-LacZ knock-in alleles 23 were generated and maintained in our laboratory. Tie2-Cre, Vav1-Cre, Dermo1-Cre and β-actin-GFP transgenic mice were obtained from Jackson Laboratory. VE-cadherin-Cre ERT2 transgenic mice were provided by ML Iruela-Arispe (University of California, Los Angeles) 66 . Littermate controls of both sexes were used in all experiments. All mouse strains were backcrossed into the C57BL/6J background for at least 7 generations. To inhibit Notch signaling in vivo, timed pregnant mice were injected subcutaneously with 100 mg/kg DAPT (Tocris Bioscience) dissolved in 10% ethanol and 90% corn oil at E7.5, E8.5 and E9.5 with the embryos dissected at E10.5 6 . Gene inactivation in Snail1 LacZ/fl ;VE-cadherin-Cre-ERT2 + embryos was triggered by i.p. injections of 150 μl of tamoxifen solution (10 mg/ml, dissolved in 1:10 ethanol/corn oil; Sigma) into pregnant females at E11.5 and E13.5. Gene inactivation in pups was triggered by i.p. injections of 50 μl tamoxifen solution (10 mg/ml) at p1 and p3. Eyes were retrieved from pups at p6 and fixed in 4% paraformaldehyde-PBS overnight at 4°C. Retinas were dissected and subjected to whole-mount PECAM-1.
Hematopoietic Colony Forming Assay
For hematopoietic colony forming assays, yolk sacs were isolated and incubated with 0.1% Collagenase D (Roche) in Hank's PBS containing 10% FCS and Pen/Strep for 1 h at 37°C with occasional agitation to aid dispersion of the tissue 67 . The cells were then washed and counted. For colony-forming unit (CFU) assays, 1.5×10 4 cells were seeded into 1 ml of methocellulose media supplemented with IL3, IL6 and SCF (M3434, Stem Cell Technologies). Clones (> 30 cells) were scored as myeloid (CFU-C) or erythroid (BFU-E) at day 7 of culture.
Allantois Explant Culture
Allantoises were dissected from E8.25 mouse embryos, and placed individually on gelatincoated chamber wells as described 16 . Explants were the cultured in DMEM medium containing 15% fibronectin-depleted FBS for 24 h. In selected experiments, allantois explants were cultured in vitro in the presence of 8 μM DAPT 6 . Pre-cultured or postcultured explants were fixed in 4% paraformaldehyde-PBS and subjected to anti-PECAM-1 immunofluorescence or TUNEL assay as described above.
Immunofluorescence Staining
Embryos or yolk sacs were fixed in 4% paraformaldehyde-PBS for 2 h, permeabilized in 100% methanol for 30 min at −20°C, and incubated in blocking buffer (5% goat serum in PBS) containing anti-PECAM-1 primary antibody (1:500, BD Biosciences) overnight at 4°C, followed by incubation with secondary antibodies (1:400, Alexa-Fluor 488-labeled, Invitrogen) in blocking buffer for 2 h. For frozen sections, allantois explant cultures or ECs, tissues/cells were fixed in 4% paraformaldehyde-PBS, permeabilized in PBST (PBS plus 0.3% Triton X-100), and incubated in blocking buffer (5% goat or donkey serum plus 2% BSA in PBS) with primary antibodies directed against PECAM-1 (1:500), α-SMA (1:500, Abcam), Dll4 or ephrin B2 (1:200, R & D Systems), followed by incubation with secondary antibodies (1:400, Invitrogen). All images were processed using Image J and Photoshop CS5. Relative vascular density, vessel length and branch points were determined in multiple fixed areas of view in 3 or more WT versus LOF embryos, yolk sacs, allantois explants or EC xenografts as described 68, 69 .
EC Isolation and Culture
EC isolation was performed as described previously with modifications 70 . Briefly, E10.5 Snail1 fl/fl embryos (of either male or female sex) or adult lungs (isolated from female mice) were dissected in ice-cold PBS and digested in a mixture of collagenase type I (Worthington), DNase I (Sigma-Aldrich) and dispase (Invitrogen) for 30 min at 37°C. ECs were then separated using Dynabeads (Invitrogen) coated with anti-PECAM-1 antibody and cultured in DMEM medium supplemented with 20% fetal bovine serum (FBS, Invitrogen) and EC growth supplement (BD Biosciences). Confluent ECs were trypsinized and separated using Dynabeads coated with anti-ICAM-1 antibody (BD Biosciences). Following two rounds of sorting, the purity of ECs is ~90% and the cells were used within two passages of their initial isolation. To obtain Snail1 WT and KO ECs, cells were infected with adenoviral-βGal or adenoviral-Cre (MOI, 50), respectively. For in vitro assessments of EC morphogenesis, Snail1 WT and KO ECs were cultured atop Matrigel-coated dishes (BD Biosciences) in the absence or presence of DAPT (8 μm) for 12 h and imaged 4 . In selected experiments, ECs were freshly isolated from E10.5 WT and Snail1 LOF embryos using Dynabeads coated with anti-PECAM1 antibody, and subjected to microarray gene expression and qRT-PCR analyses.
Angiogenic Xenotransplant Assay
Angiogenic xenotransplant assays were performed as described previously with modifications 30 . In brief, cultured ECs derived from lungs of 1-month-old Snail1 fl/fl /β-Actin-GFP + mice were transduced in vitro with Adeno-Cre or Adeno-β-gal expression vectors. The recovered WT and Snail1-KO ECs were re-suspended in a 1:1 Matrigel mixture in the presence of PBS or 100 ng/ml VEGF-165 (R & D Systems) and absorbed into poly-Llactic acid scaffolds (1×10 6 ECs each). The matrix implants were transplanted s.c. into male SCID mice, retrieved 14 d after implantation and imaged by phase contrast microscopy, GFP fluorescence and whole-mount PECAM-1 immunofluorescent staining.
Microarray Gene Expression Assay and Quantitative RT-PCR (qRT-PCR)
Cultured WT, Snail1 fl/fl , Snail1-deleted or Snail1 KO embryonic ECs were isolated as described previously with modifications 70 . Total RNA was isolated with the RNeasy Mini Kit (Qiagen), labeled, and then hybridized to Mouse 430 2.0 cDNA microarrays (Affymetrix). Differentially expressed probe sets were determined by using a minimum fold change of 1.5 in Snail1-deleted ECs relative to Snail1 fl/fl control ECs as described previously 48 . For RT-qPCR analysis, 0.5 μg total RNA was reverse transcribed into complementary DNA (cDNA) using SuperScript III cDNA Synthesis Kit (Invitrogen). cDNA was amplified using SYBR Green PCR mix (Applied Biosystems), and qPCR was carried out using an ABI PRISM 7900HT (Applied Biosystems) sequence detection system. For all samples, the expression level, normalized to the housekeeping gene encoding GAPDH, was determined with the comparative threshold cycle (Ct) method (primers are listed in Supplementary Table 1 ).
Immunoblot and ChIP Assays
Cultured WT and Snail1 KO ECs were stimulated with recombinant VEGF-A/164 (100 ng/ ml), bFGF (20 ng/ml) or TGF-β1 (10 ng/ml) (all from R&D Systems), and the cell lysates were subjected to immunoblot assay using antibodies against Snail1 (1:1000), Snail2 (1:1000), N1ICD (1:1000), p-ERK1/2 (Y202/204) (1:1000), p-Akt (S473) (1:500), p-GSK3β (S9) (1:2000), GSK3β (1:5000), β-actin (1:10,000) (all from Cell Signaling), Dll4 (1:1000), α-SMA (1:5000) (both from Abcam), and Claudin 5 (1:5000, Millipore). For ChIP analysis, ECs were electroporated with FLAG-Snail1 expressing vector using Amaxa Basic Nucleofector kit (Lonza) and subjected to ChIP assay as described previously 38 .
Luciferase Reporter Assay
A 3.7 kb fragment of the mouse Dll4 promoter (-3631~+76) subcloned in the pGL3 basic vector was kindly provided by T. Kume (Northwestern University, Chicago, IL). The minimal Dll4 promoter (−481~+76) was amplified from the 3.7 kb fragment of Dll4 promoter and subcloned in the pGL3 basic vector (Promega). The Dll4-MUT was generated by mutating the Snail1 binding sites (E-boxes) CANNTG to AANNTA using the QuikChange Site-Directed Mutagenesis kit (Stratagene). A 1.2 kb fragment of the mouse Notch1 promoter (−1039~+182) was obtained from GeneCopoeia, Inc. Dual-luciferase reporter assays were performed according to the manufacturer's instructions (Promega).
Statistical Analysis
Statistical analysis was performed with the Student's t test or by ANOVA. * p < 0.05, ** p < 0.01, $$ p < 0.01, ## p < 0.01. All experiments were repeated three or more times.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. (m-r) Cross-sections from E10.5 WT and Snail1 LOF mutant embryos were co-stained with anti-PECAM-1 and anti-ephrin B2 antibodies. Cell nuclei were stained with DAPI (blue). (f) Lysates from cultured control or Snail1-deleted ECs were subjected to ChIP analysis using antibodies directed against H3K4me2, H3K4me3 or H3K9Ac and Dll4 occupancy determined by qPCR. (mean ± SEM; n=3). **p < 0.01, Student's t test. (g,h) Control and Snail1-deleted ECs were treated with vehicle or VEGF for 12 h, and subjected to Western blot (g) or RT-qPCR analysis (h), respectively. Western results are representative of 3 experiments with RT-qPCR results presented as mean ± SEM (n=3). **p < 0.01, ANOVA. (i) WT ECs were stimulated with vehicle, VEGF (100 ng/ml) or bFGF (20 ng/ml) for 12 h and subjected to Western blot analysis. Results are representative of 3 or more experiments. (j,k) WT ECs were pretreated with U0126 (20 μM), LY294002 (10 μM) or sanguinarine (2.5 μM) for 1 h followed by stimulation with VEGF or bFGF for 12 h. Cell lysates were prepared and subjected to Western blot (j) and RT-qPCR (k) analysis, respectively. Western results representative of 3 experiments with RT-qPCR results presented as mean ± SEM (n=3). **p < 0.01, ANOVA. (l) WT ECs were pretreated with vehicle or DAPT (8 μM) for 1 h followed by stimulation with VEGF (100 ng/ml) for 12 h. Cell lysates were prepared and subjected to Western blot analysis. Results are representative of 3 experiments.
